Related Experiment Video
Updated: Jul 4, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer
Yonggang Liang1, Xiaoqiang Zhang1, Jinhua Peng1
1Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Objective:
tRNA-derived small RNAs (tsRNAs) are novel non-coding RNAs with various functions in multiple cancers. Nevertheless, whether vitamin D executes its function in mitochondrial dysfunction and non-small cell lung cancer (NSCLC) progression through tsRNAs remains obscure.
Methods:
Differentially expressed tsRNAs between control and vitamin D-treated H1299 cells were acquired by small RNA sequencing. Cell and animal experiments were implemented to elucidate the impacts of vitamin D and tsRNA on mitochondrial dysfunction and NSCLC progression. Dual-luciferase reporter assay, quantitative real-time PCR, western blot and recovery experiments were applied to determine the mechanism of tsRNA in NSCLC.
Results:
We discovered that vitamin D receptor resulted in decreased mitochondrial-related functions and vitamin D caused mitochondrial dysfunction of NSCLC cells. tsRNA-07804 was remarkably upregulated in vitamin D-treated H1299 cells. Functional experiments indicated that vitamin D led to mitochondrial dysfunction, repressed the proliferation, migration, invasion, and promoted apoptosis of H1299 cells via regulating tsRNA-07804. Mechanistically, tsRNA-07804 induced mitochondrial dysfunction and inhibited the malignancy of H1299 cells by suppressing CRKL expression. In vivo experiments showed that vitamin D inhibited the tumor growth in NSCLC by increasing tsRNA-07804 expression. Moreover, clinical sample analysis unveiled that tsRNA-07804 had a negative correlation with CRKL.
Conclusions:
In conclusion, our study proved that vitamin D induced mitochondrial dysfunction and suppressed the progression of NSCLC through the tsRNA-07804/CRKL axis. Overall, these results unveiled that tsRNA-07804 might act as a potential therapeutic target for NSCLC.
Insights
Vitamin D combats non-small cell lung cancer (NSCLC) by regulating tRNA-derived small RNA (tsRNA)-07804, which targets CRKL, thereby improving mitochondrial function and inhibiting tumor growth.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- tRNA-derived small RNAs (tsRNAs) are emerging non-coding RNAs with diverse roles in cancer.
- The precise mechanisms by which vitamin D influences mitochondrial dysfunction and non-small cell lung cancer (NSCLC) progression via tsRNAs are not fully understood.
Purpose of the Study:
- To investigate the role of vitamin D in regulating tsRNAs and their impact on mitochondrial dysfunction and NSCLC progression.
- To elucidate the specific tsRNA involved and its downstream molecular targets in NSCLC.
Main Methods:
- Small RNA sequencing was used to identify differentially expressed tsRNAs in vitamin D-treated NSCLC cells.
- In vitro cell assays and in vivo animal models were employed to assess the functional effects of vitamin D and tsRNA-07804 on NSCLC.
- Mechanism was explored using dual-luciferase reporter assays, qPCR, and western blotting to examine the tsRNA-07804/CRKL interaction.
Main Results:
- Vitamin D treatment led to mitochondrial dysfunction in NSCLC cells and upregulated tsRNA-07804.
- tsRNA-07804 mediated vitamin D's effects, inhibiting NSCLC proliferation, migration, and invasion while promoting apoptosis by suppressing CRKL expression.
- In vivo studies confirmed that vitamin D inhibited tumor growth by increasing tsRNA-07804 expression, and clinical samples showed a negative correlation between tsRNA-07804 and CRKL.
Conclusions:
- Vitamin D suppresses NSCLC progression and mitochondrial dysfunction via the tsRNA-07804/CRKL axis.
- tsRNA-07804 emerges as a potential therapeutic target for NSCLC treatment.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

